Updated Jul 16, 2026
Munshi Amit has filed 3 SEC Form 4 filings across 3 companies in the last 90 days — buying. Lifetime open-market purchases: $500K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-10 | ARQT | Arcutis Biotherapeutics, Inc. | A — Grant or award | 5.8K | $0.00 | |
| 2026-02-25 | IKT | Inhibikase Therapeutics, Inc. | D — Derivative transaction | 19.1K | $0.00 | |
| 2025-02-21 | IKT | Inhibikase Therapeutics, Inc. | A — Grant or award | 57.3K | $0.00 | |
| 2024-10-23 | IKT | Inhibikase Therapeutics, Inc. | P — Open-market purchase | 365.0K | $1.37 | $500K |
Munshi Amit is a corporate insider — currently tracked as Insider of Inhibikase Therapeutics, Inc. (IKT). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 1 open-market purchases ($500K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Munshi Amit profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.